Sun Pharmaceutical Industries saw the highest growth of 3.99% in patent filings in April and 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 3.99% and grants by 0.77%. GlobalData’s DataBook provides a comprehensive analysis of Sun Pharmaceutical Industries‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Sun Pharmaceutical Industries has been focused on protecting inventions in European Patent Office(EPO) with 13 publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 31% filings and 18% grants. The European Patent Office(EPO), United States(US), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where Sun Pharmaceutical Industries is filings its patents. Among the top granted patent authorities, Sun Pharmaceutical Industries has 18% of its grants in European Patent Office(EPO), 18% in Israel(IL) and 12% in Australia(AU).
Roche and Johnson & Johnson could be the strongest competitors for Sun Pharmaceutical Industries
Patents related to healthtech and rare diseases lead Sun Pharmaceutical Industries's portfolio
Sun Pharmaceutical Industries has the highest number of patents in healthtech followed by, rare diseases and remote patient monitoring. For healthtech, nearly 27% of patents were filed and 22% of patents were granted in Q2 2024.
Obesity related patents lead Sun Pharmaceutical Industries portfolio followed by type 2 diabetes, and diabetes
Sun Pharmaceutical Industries has highest number of patents in obesity followed by type 2 diabetes, diabetes, keratoconjunctivitis sicca (dry eye), and packaging. For obesity, nearly 9% of patents were filed and 11% of patents were granted in Q2 2024.
For comprehensive analysis of Sun Pharmaceutical Industries's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
